Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for TNBC
NCT01289353Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Mar 2009
- Primary completion
- Jul 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in breast cancer, sponsored by NYU Langone Health. Started Mar 2009; status: completed.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01289353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289353.